granted
on 30 Jan 2024
Last Applicant/ Owned by
63 Pinnacle Drive
Port Jefferson
NY
11777
Serial Number
90346293 filed on 28th Nov 2020
Registration Number
N/A
Correspondent Address
George Likourezos
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Drug delivery system, namely, an intramuscular autoinjector and an intramuscular drug delivery autoinjector; drug delivery system for administering drugs for the treatment or prevention of neurological symptoms or conditions associated with concussion or traumatic brain injury, namely, an intramuscular autoinjector, and an intramuscular needle-based injection system; an intramuscular needle-based Read More
Medical services, namely, providing medical services using drug delivery systems, pill packets, pharmaceuticals, antibiotics, and drugs for the treatment or prevention of neurological symptoms or conditions associated with concussion or traumatic brain injury
Retail store services featuring drug delivery systems, pill packets, pharmaceuticals, antibiotics, and drugs for the treatment or prevention of neurological symptoms or conditions associated with concussion or traumatic brain injury
Drug delivery system, namely, an intramuscular autoinjector and an intramuscular drug delivery autoinjector; drug delivery system for administering drugs for the treatment or prevention of neurological symptoms or conditions associated with concussion or traumatic brain injury, namely, an intramuscular autoinjector, and an intramuscular needle-based injection system; an intramuscular needle-based injection system for administering drugs for the treatment or prevention of neurological symptoms or conditions associated with concussion or traumatic brain injury; drug delivery system for reversing the damage caused by concussion or traumatic brain injury, namely, intramuscular autoinjector and an intramuscular needle-based injection system
Pharmaceuticals, namely, a partial agonist of N-methyl-D-aspartame (NMDA) receptors at low dose and a partial antagonist of NMDA at high dose, an inhibitor of microglial activation, and a modulator of NMDA receptors; antibiotics; pharmaceuticals and antibiotics for the treatment or prevention of neurological symptoms or conditions associated with concussion or traumatic brain injury; pharmaceuticals and antibiotics for reversing the damage caused by concussion or traumatic brain injury
No 90346293
No Service Mark
No 2972-2
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 01st Feb 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 30th Jan 2024 | SOU TEAS EXTENSION RECEIVED |
| 30th Jan 2024 | SOU EXTENSION 4 FILED |
| 30th Jan 2024 | SOU EXTENSION 4 GRANTED |
| 28th Jul 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 26th Jul 2023 | SOU TEAS EXTENSION RECEIVED |
| 26th Jul 2023 | SOU EXTENSION 3 FILED |
| 26th Jul 2023 | SOU EXTENSION 3 GRANTED |
| 28th Jan 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 26th Jan 2023 | SOU TEAS EXTENSION RECEIVED |
